PFE Operating Cash Flow (Statement)

Pfizer · Operating Cash Flow (Statement)

PFE logo

PFE Operating Cash Flow (Statement)

Latest reported$835.00M
PFE Quarterly Cash from Operations ($112.00M → $835.00M)
High-resolution chart · PNG

PFE operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
835,000,000
2,615,000,000
5,349,000,000
4,603,000,000
-582,000,000
2,335,000,000
6,721,000,000
6,714,000,000
-1,781,000,000
1,090,000,000
5,240,000,000
3,456,000,000
-1,209,000,000
1,213,000,000
8,582,000,000
5,974,000,000
8,169,000,000
6,541,000,000
5,914,000,000
10,829,000,000
11,299,000,000
4,538,000,000
5,625,000,000
2,090,000,000
3,555,000,000
3,133,000,000
3,769,000,000
4,510,000,000
2,611,000,000
1,698,000,000
4,738,000,000
5,259,000,000
3,847,000,000
1,983,000,000
6,742,000,000
4,887,000,000
3,252,000,000
1,589,000,000
5,972,000,000
4,699,000,000
3,579,000,000
1,651,000,000
4,713,000,000
5,024,000,000
4,090,000,000
685,000,000
5,398,000,000
4,463,000,000
4,087,000,000
2,935,000,000
5,786,000,000
5,908,000,000
3,830,000,000
2,241,000,000
5,256,000,000
5,003,000,000
4,021,000,000
2,774,000,000
5,261,000,000
4,439,000,000
5,898,000,000
4,642,000,000
6,258,000,000
6,683,000,000
4,873,000,000
-6,360,000,000
4,825,000,000
4,101,000,000
4,514,000,000
3,147,000,000
5,973,000,000
3,952,000,000
5,042,000,000
3,271,000,000
3,767,000,000
4,678,000,000
3,665,000,000
1,243,000,000
4,476,000,000
4,014,000,000
5,143,000,000
3,961,000,000
4,737,000,000
3,013,000,000
3,809,000,000
3,174,000,000
5,990,000,000
5,176,000,000
3,591,000,000
1,583,000,000
4,396,000,000
2,873,000,000
2,133,000,000
2,337,000,000
3,734,000,000
2,315,000,000
2,560,000,000
1,574,000,000
2,473,000,000
2,580,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.